Cargando…

Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis

OBJECTIVES: To evaluate the psychometric properties (and identify specific anomalies to be resolved) of urinary and sexual function scales of the Symptom Tracking and Reporting (STAR) instrument for use in clinical practice with individual men using Rasch analysis. DESIGN: Prospective cohort study....

Descripción completa

Detalles Bibliográficos
Autores principales: Protopapa, Eva, van der Meulen, Jan, Moore, Caroline M, Smith, Sarah C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668365/
https://www.ncbi.nlm.nih.gov/pubmed/33191249
http://dx.doi.org/10.1136/bmjopen-2019-035436
_version_ 1783610472257290240
author Protopapa, Eva
van der Meulen, Jan
Moore, Caroline M
Smith, Sarah C
author_facet Protopapa, Eva
van der Meulen, Jan
Moore, Caroline M
Smith, Sarah C
author_sort Protopapa, Eva
collection PubMed
description OBJECTIVES: To evaluate the psychometric properties (and identify specific anomalies to be resolved) of urinary and sexual function scales of the Symptom Tracking and Reporting (STAR) instrument for use in clinical practice with individual men using Rasch analysis. DESIGN: Prospective cohort study. SETTING: 9 UK surgery centres in secondary care. PARTICIPANTS: 403 men diagnosed with prostate cancer and completed at least one questionnaire immediately before and at 1 or 3 months after radical prostatectomy. PRIMARY AND SECONDARY OUTCOMES: STAR instrument before surgery and 1 and 3 months afterwards. RESULTS: Neither scale fitted the Rasch model (both scales p<0.001). Both urinary (seven items) and sexual function (six items) had disordered thresholds, suggesting response categories are not working as intended. Both scales (three urinary items; five sexual function items) showed problems with item fit (large fit residuals, significant χ(2), an inspection of item characteristic curves). Both scales showed items that were unstable over time (differential item functioning (DIF) by time). Both scales (four pairs of items in each scale) showed local response dependency (residual correlations >0.2 above the average). Internal consistency was acceptable at the group level for both scales. Targeting was poor for both scales, indicating an inadequate match between the location of items and the distribution of the patients, suggesting that the underlying constructs that the scales purport to measure are not clear. CONCLUSION: Using Rasch analysis as a diagnostic tool, we identified that both the urinary and the sexual function scales have issues that need to be resolved before STAR can be used with confidence in clinical practice. The sexual function scale, in particular, is unlikely to provide precise estimates for the outcomes experienced by men after radical prostatectomy. These results demonstrate the need to evaluate the suitability of any patient-reported outcome measure before implementation in routine clinical practice, preferably using modern psychometric methods.
format Online
Article
Text
id pubmed-7668365
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-76683652020-11-24 Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis Protopapa, Eva van der Meulen, Jan Moore, Caroline M Smith, Sarah C BMJ Open Urology OBJECTIVES: To evaluate the psychometric properties (and identify specific anomalies to be resolved) of urinary and sexual function scales of the Symptom Tracking and Reporting (STAR) instrument for use in clinical practice with individual men using Rasch analysis. DESIGN: Prospective cohort study. SETTING: 9 UK surgery centres in secondary care. PARTICIPANTS: 403 men diagnosed with prostate cancer and completed at least one questionnaire immediately before and at 1 or 3 months after radical prostatectomy. PRIMARY AND SECONDARY OUTCOMES: STAR instrument before surgery and 1 and 3 months afterwards. RESULTS: Neither scale fitted the Rasch model (both scales p<0.001). Both urinary (seven items) and sexual function (six items) had disordered thresholds, suggesting response categories are not working as intended. Both scales (three urinary items; five sexual function items) showed problems with item fit (large fit residuals, significant χ(2), an inspection of item characteristic curves). Both scales showed items that were unstable over time (differential item functioning (DIF) by time). Both scales (four pairs of items in each scale) showed local response dependency (residual correlations >0.2 above the average). Internal consistency was acceptable at the group level for both scales. Targeting was poor for both scales, indicating an inadequate match between the location of items and the distribution of the patients, suggesting that the underlying constructs that the scales purport to measure are not clear. CONCLUSION: Using Rasch analysis as a diagnostic tool, we identified that both the urinary and the sexual function scales have issues that need to be resolved before STAR can be used with confidence in clinical practice. The sexual function scale, in particular, is unlikely to provide precise estimates for the outcomes experienced by men after radical prostatectomy. These results demonstrate the need to evaluate the suitability of any patient-reported outcome measure before implementation in routine clinical practice, preferably using modern psychometric methods. BMJ Publishing Group 2020-11-14 /pmc/articles/PMC7668365/ /pubmed/33191249 http://dx.doi.org/10.1136/bmjopen-2019-035436 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Urology
Protopapa, Eva
van der Meulen, Jan
Moore, Caroline M
Smith, Sarah C
Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis
title Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis
title_full Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis
title_fullStr Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis
title_full_unstemmed Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis
title_short Assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a Rasch analysis
title_sort assessment of a patient-reported outcome measure in men with prostate cancer who had radical surgery: a rasch analysis
topic Urology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668365/
https://www.ncbi.nlm.nih.gov/pubmed/33191249
http://dx.doi.org/10.1136/bmjopen-2019-035436
work_keys_str_mv AT protopapaeva assessmentofapatientreportedoutcomemeasureinmenwithprostatecancerwhohadradicalsurgeryaraschanalysis
AT vandermeulenjan assessmentofapatientreportedoutcomemeasureinmenwithprostatecancerwhohadradicalsurgeryaraschanalysis
AT moorecarolinem assessmentofapatientreportedoutcomemeasureinmenwithprostatecancerwhohadradicalsurgeryaraschanalysis
AT smithsarahc assessmentofapatientreportedoutcomemeasureinmenwithprostatecancerwhohadradicalsurgeryaraschanalysis